<?xml version='1.0' encoding='utf-8'?>
<document id="31788248"><sentence text="Heart insufficiency after combination of verapamil and metoprolol: A fatal case report and literature review."><entity charOffset="41-50" id="DDI-PubMed.31788248.s1.e0" text="verapamil" /><entity charOffset="55-65" id="DDI-PubMed.31788248.s1.e1" text="metoprolol" /><pair ddi="false" e1="DDI-PubMed.31788248.s1.e0" e2="DDI-PubMed.31788248.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31788248.s1.e0" e2="DDI-PubMed.31788248.s1.e1" /></sentence><sentence text="The combination of verapamil or diltiazem with beta-blockers should be avoided because of potentially profound adverse effects on AV (atrioventricular) nodal conduction, heart rate, or cardiac contractility"><entity charOffset="19-28" id="DDI-PubMed.31788248.s2.e0" text="verapamil" /></sentence><sentence text=" This effect is unpredictable but may be enhanced due to CYP2D6 poor metabolizer status which could be a special vulnerability factor" /><sentence text="" /></document>